← Back to Search

Other

Sensi-IP toothpaste for Tooth Sensitivity

N/A
Waitlist Available
Research Sponsored by IR Scientific Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial studies if a toothpaste with Sensi-IP +NaF can reduce tooth sensitivity in adults more than just NaF toothpaste. 46 participants aged 18-80 will be enrolled & evaluated for efficacy & adverse events.

Who is the study for?
Adults aged 18-80 with sensitive teeth, willing to avoid other dental treatments and oral hygiene products during the trial. Participants must have at least two sensitive teeth in different quadrants of the mouth, anterior to the molars. Excluded are those pregnant, breastfeeding, with recent dental work or desensitizing treatments, active oral issues like ulcers or severe gum disease, certain medical conditions affecting saliva flow or sensitivity perception.Check my eligibility
What is being tested?
The study compares Sensi-IP toothpaste combined with sodium fluoride (NaF) against a standard NaF toothpaste for reducing tooth sensitivity over 14 days. It's a randomized and double-blinded pilot trial involving two groups: one using Sensi-IP + NaF toothpaste and another using only NaF toothpaste.See study design
What are the potential side effects?
Potential side effects may include reactions to ingredients in the Sensi-IP toothpaste such as flavor components which could cause allergic responses or further sensitivity in some individuals.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline at Day 14 using the Schiff Airblast Sensitivity Score
Secondary outcome measures
Change from baseline at Day 14 using the Visual Analogue Score (VAS) for pain following evaporative stimuli
Change from baseline at Day 14 using the Yeaple probe assessment
Other outcome measures
The occurrence of adverse events that are possibly, probably, or definitely related to the product

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sensi-IP toothpasteExperimental Treatment1 Intervention
Sodium Fluoride Toothpaste with Sensi-IP
Group II: Sodium fluoride toothpasteActive Control2 Interventions
Sodium Fluoride Toothpaste
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sensi-IP toothpaste
2023
N/A
~50

Find a Location

Who is running the clinical trial?

IR Scientific Inc.Lead Sponsor
IR Scientific IncLead Sponsor
Heather DoucetteStudy DirectorIR Scientific Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is registration still open for participants in this research project?

"Affirmative. As per the information hosted on clinicaltrials.gov, this trial is recruiting participants now. The initial posting was created on November 6th 2023 and the most recent update occurred December 3rd of that same year. We are aiming to enrol 46 patients at one medical centre in total."

Answered by AI

Do I meet the criteria to be recruited for this experiment?

"Eligibility requirements for this study entail participants feeling tooth sensitivity and having an age between 18 to 80. A maximum of 46 individuals can join the trial."

Answered by AI

Is this research study admitting participants who are sixty or older?

"This clinical trial is available to adults aged 18-80. 90 trials are currently open for those under the age of majority and 172 trails have been opened up for elderly patients over 65 years old."

Answered by AI

How many individuals have been enrolled in this medical experiment?

"Affirmative. According to the information provided on clinicaltrials.gov, this trial is actively recruiting participants with a start date of November 6th 2023 and an update posted December 3rd 2023. The study requires 46 patients from 1 medical centre for enrolment."

Answered by AI
~31 spots leftby May 2025